ASCO Value Framework
On May 31, 2016, an updated version of the ASCO Value Framework—which assesses the value of new cancer therapies based on clinical benefit, side effects, and improvements in patient symptoms or quality of life in the context of cost—was published in the Journal of Clinical Oncology.
Developed and refined by the ASCO Value in Cancer Care Task Force, the updated framework comes following a review of more than 400 comments on the conceptual value framework from a wide range of stakeholders. The updated framework will serve as the basis for a user-friendly software tool that doctors can use to inform shared decision-making with patients.
The ASCO Value Framework is just one part of ASCO’s broader, multi-faceted effort to achieve high-quality, high-value care for all patients with cancer that includes the Patient-Centered Oncology Model, Choosing Wisely, CancerLinQ, and the Quality Oncology Practice Initiative (QOPI).